Regarding the interpretation of “offering for the purpose” (of making, using etc.) in the sense of Article 53(1)(b) Dutch Patent Act, the Supreme Court held that offering has to be construed broadly and is not restricted to offering for sale. The defendant submitted its generic product for listing in G-Standaard, the database for medicinal products through pharmacies, before expiration of the patent covering this substance (i.e. Ondansetron) , accompanied by a side letter to all database users that the product would not be put on the market before the expiration of the patent. The Supreme Court sanctioned the Appeal Court’s finding that this qualifies as “offering” and is therefore prohibited.

Click here  for the full text of this case.

A summary of this case will be posted on http://www.KluwerIPCases.com


_____________________________

To make sure you do not miss out on regular updates from the Kluwer Patent Blog, please subscribe here.


Kluwer IP Law

The 2022 Future Ready Lawyer survey showed that 79% of lawyers think that the importance of legal technology will increase for next year. With Kluwer IP Law you can navigate the increasingly global practice of IP law with specialized, local and cross-border information and tools from every preferred location. Are you, as an IP professional, ready for the future?

Learn how Kluwer IP Law can support you.

Kluwer IP Law
This page as PDF